CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts Jazz Pharmaceuticals PT to $283 From $280, Maintains Overweight Rating

Neutral
AI Analysis

Summary

Morgan Stanley adjusted its price target for Jazz Pharmaceuticals from $280 to $283 while maintaining an Overweight rating.

Importance:2/10
Sentiment:
0.10
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 11, 2026 12:16 PM

Read Original